Sunday, November 30, 2025 4:10:44 PM
ASw,
Thanks for reposting your free psychic reading 😶
You should share your MAA status update with Dr. Evans, Dr. Ashkan, & NICE over in the U.K. because they’ve been waiting to hear an update about MHRA’s decision.
“Dr. Luke Evans, MP for Hinckley and Bosworth, has served since November 2024 as a Shadow Parliamentary Under-Secretary for Health and Social Care, an official opposition role that helps shape his party’s health agenda and lead its position on national health policy.”
NWBO: Timestamp 8:40
Full Speech
Dr. Luke Named Shadow Health Minister, Nov 2024
About Dr. Luke
Briefing to Parliamentarians – October 2025
Tessa Jowell Centre of Excellence
NICE UK 🇬🇧 DCVax-L
“NICE is continuing to liaise with Northwest Biotherapeutics ...”
Fud Flood 🌊
Thanks for reposting your free psychic reading 😶
You should share your MAA status update with Dr. Evans, Dr. Ashkan, & NICE over in the U.K. because they’ve been waiting to hear an update about MHRA’s decision.
“Dr. Luke Evans, MP for Hinckley and Bosworth, has served since November 2024 as a Shadow Parliamentary Under-Secretary for Health and Social Care, an official opposition role that helps shape his party’s health agenda and lead its position on national health policy.”
NWBO: Timestamp 8:40
Full Speech
Dr. Luke Named Shadow Health Minister, Nov 2024
About Dr. Luke
Briefing to Parliamentarians – October 2025
Tessa Jowell Centre of Excellence
NICE UK 🇬🇧 DCVax-L
“NICE is continuing to liaise with Northwest Biotherapeutics ...”
Fud Flood 🌊
Bullish
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
